FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752), which is ...
Assoumou is an infectious diseases physician-scientist at Boston Medical Center. Miller is a research data associate within Dr. Assoumou’s I-CARE (Infectious Complications Assessment and Research) lab ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The long-acting ...
Sample blood collection tube with HIV test label on HIV infection screening test form. (Photo credit: Shutterstock.com / Room's Studio) A non-reactive HIV test result generally means good news – you ...
The test stick is swabbed along the upper and lower gum once and placed into the test tube for 20 minutes before reading the results. The Food and Drug Administration (FDA) has expanded the approval ...
Hosted on MSN
HIV testing in A&E 'quite literally saving lives'
Hundreds of people have been diagnosed with either HIV or hepatitis B since A&E departments across the Midlands started routine testing - a process said to be "quite literally saving lives". The ...
PITTSBURGH – March 21, 2024 – Researchers who are developing a dual-purpose vaginal ring to protect women against both HIV and unplanned pregnancy for a month at a time have begun a study to evaluate ...
– Newly Presented Results, to be Published in The New England Journal of Medicine, Include Adherence and Pharmacokinetics Data; Data Underscore High Efficacy and Safety Profile of Lenacapavir Among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback